Impact of evolving practices on SARS-CoV-2 positive mothers and their newborns in the largest public healthcare system in America

J Perinatol. 2021 May;41(5):970-980. doi: 10.1038/s41372-021-01023-8. Epub 2021 Mar 5.

Abstract

Objective: The impact of evolving guidelines and clinical practices on SARS-CoV-2-positive dyads across New York City Health and Hospitals during the early peak of COVID-19.

Design: A retrospective cohort study of positive-positive (P/P), positive-negative (P/N), and positive-untested (P/U) dyads delivered from March 1 to May 9, 2020. Wilcoxon rank sum, Chi-squared, and Fisher exact tests were used to analyze demographics, clinical variables, and system-wide management practices.

Result: A total of 2598 mothers delivered. 23.8% (286/1198) of mothers tested for SARS-CoV-2 were positive. 89.7% (260/290) newborns of SARS-CoV-2-positive mothers were tested and 11 were positive. Positive-positive newborns were more likely to be breastfed (81%), be admitted to NICU, and have longer length of stay (7.5 days) than P/N and P/U newborns.

Conclusion: Our study shows that varied testing, feeding, and isolation practices resulted in favorable short-term outcomes for SARS-CoV-2-positive mothers and their newborns. High-risk populations can be safely and effectively treated in resource-limited environments.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Breast Feeding / statistics & numerical data*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 Testing
  • Female
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Infectious Disease Transmission, Vertical / statistics & numerical data*
  • Intensive Care, Neonatal / statistics & numerical data
  • Length of Stay / statistics & numerical data
  • Male
  • Neonatal Screening / methods
  • New York City / epidemiology
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / epidemiology*
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2 / isolation & purification